UNSPSC 85494313: Revision of nonautologous tissue substitute in aortic valve, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in aortic valve, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02WF4KZ

UNSPSC 85494313 Revision of nonautologous tissue substitute in aortic valve, percutaneous endoscopic approach (Commodity) shows minimal relevance to the recent state and local procurement activity tagged under this code. The code's nominal scope describes a specific cardiac surgical procedure, yet the recent opportunities reflect a broader mix of health services procurement—medical record summarization for pension disability determinations, surgical benefit carve-out networks for municipal employees, occupational health surveillance, juvenile detention medical services, pharmacy benefit management, and temporary health professional staffing. None of these opportunities involve the specialized cardiac valve procedure the code names. State and local procurement offices appear to have applied this code inconsistently or as a catch-all for health services categories that do not map cleanly to the Commodity's intended scope.

The issuing bodies across recent opportunities span diverse public sectors: a city retirement office (Phoenix), a municipal employee health plan (Long Beach), a state transportation agency (Washington State Department of Transportation), a county juvenile probation department (Harris County, Texas), a county board of commissioners (Collier County, Florida), and a county health system (Santa Clara County, California). Geographic activity concentrates in California, Arizona, Washington, Texas, and Florida, with no clear single-state dominance. Representative opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026, $750,000 maximum over five years), Long Beach's RFP for surgical benefit carve-out services (due October 7, 2026), and the Washington State Department of Transportation's RFP for occupational medical surveillance (due October 9, 2026, with pre-bid August 31, 2026). The code's misalignment with actual procurement activity suggests that this Commodity sits below the threshold of meaningful state and local buying volume for cardiac implant revision procedures.